The data indicated that the SPP1 gene was altered in 2.19% of 411 bladder cases which were found to harbor the highest proportion of SPP1 gene amplifications with 1.22% relative to other cancer types (Figure 2A). The gene discussed is SPP1; the disease is urogenital neoplasm.